Novartis Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Novartis AG ADR
NVS Stock  USD 162.67  1.25  0.76%   
Novartis' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Novartis' valuation are provided below:
Gross Profit
43.1 B
Profit Margin
0.2467
Market Capitalization
314.5 B
Enterprise Value Revenue
5.8949
Revenue
56.7 B
There are over one hundred nineteen available fundamental ratios for Novartis, which can be analyzed over time and compared to other ratios. All traders should check Novartis' last-minute fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 111.2 B in 2026. Enterprise Value is likely to drop to about 117.3 B in 2026

Novartis Total Revenue

45.05 Billion

Check Novartis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novartis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.2 B, Interest Expense of 614.7 M or Selling General Administrative of 6.8 B, as well as many indicators such as Price To Sales Ratio of 2.91, Dividend Yield of 0.0241 or PTB Ratio of 6.11. Novartis financial statements analysis is a perfect complement when working with Novartis Valuation or Volatility modules.
  
Build AI portfolio with Novartis Stock
Check out the analysis of Novartis Correlation against competitors.

Novartis Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets104.3 B115.6 B117.4 B
Pretty Stable
Short and Long Term Debt Total20 B37 B25.4 B
Slightly volatile
Other Current Liabilities9.9 B14.5 B11.5 B
Slightly volatile
Total Current Liabilities22.7 B27.3 B25.6 B
Slightly volatile
Total Stockholder Equity56.6 B46.1 B61.2 B
Pretty Stable
Property Plant And Equipment Net13.4 B12.4 B14.1 B
Slightly volatile
Net Debt26.9 B25.6 B17.3 B
Slightly volatile
Retained Earnings57.4 B44.7 B63.1 B
Pretty Stable
Accounts Payable4.2 B4.5 B5 B
Very volatile
Cash8 B11.4 B9 B
Slightly volatile
Non Current Assets Total74.2 B85.1 B87.1 B
Very volatile
Cash And Short Term Investments13.1 B11.6 B12.1 B
Slightly volatile
Net Receivables9.4 B10.9 B9.9 B
Pretty Stable
Common Stock Total Equity776.8 M821.7 M943.7 M
Slightly volatile
Common Stock Shares Outstanding1.9 B2 B2.3 B
Slightly volatile
Short Term Investments147.2 M155 M2.9 B
Very volatile
Liabilities And Stockholders Equity104.3 B115.6 B117.4 B
Pretty Stable
Non Current Liabilities Total24.7 B41.7 B30.5 B
Slightly volatile
Inventory6 B6.3 B6.4 B
Very volatile
Other Current Assets1.7 B1.7 B2 B
Very volatile
Total Liabilities47.3 B69 B56.1 B
Slightly volatile
Property Plant And Equipment Gross14.8 B25.1 B16.3 B
Slightly volatile
Total Current Assets30.1 B30.5 B30.3 B
Slightly volatile
Capital Stock757.3 M766 M925 M
Slightly volatile
Short Term Debt6.5 B5.8 B6.9 B
Pretty Stable
Intangible Assets22.4 B29.4 B28.8 B
Pretty Stable
Common Stock757.3 M766 M925 M
Slightly volatile
Other Liabilities8.5 B8.7 B9.9 B
Very volatile
Other Assets9.8 B9 B10.9 B
Very volatile
Long Term Debt29.3 B27.9 B18.9 B
Slightly volatile
Good Will22.4 B25.6 B27.3 B
Very volatile
Property Plant Equipment13.8 B12.5 B14 B
Pretty Stable
Noncontrolling Interest In Consolidated Entity93.5 M95.5 M91.6 M
Pretty Stable
Deferred Long Term Liabilities5.8 B5.1 B4.6 B
Slightly volatile
Long Term Investments1 B1.1 B8.4 B
Slightly volatile
Short and Long Term Debt5.6 B5.5 B8.9 B
Slightly volatile
Long Term Debt Total24.1 B26.4 B20.7 B
Slightly volatile
Non Current Liabilities Other1 B957 M1.3 B
Slightly volatile
Cash And Equivalents8.3 B10.2 B6.9 B
Slightly volatile
Net Invested Capital70.7 B79.6 B93.2 B
Slightly volatile
Capital Lease Obligations1.5 B1.9 B1.9 B
Slightly volatile

Novartis Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization4.2 B5.4 B5.3 B
Slightly volatile
Selling General Administrative6.8 B13.2 B8.2 B
Slightly volatile
Selling And Marketing Expenses11.8 B14.8 B12.5 B
Slightly volatile
Total Revenue45.1 B54.8 B47.9 B
Very volatile
Gross Profit32 B41.1 B33.5 B
Slightly volatile
Other Operating Expenses35.4 B37.7 B37.8 B
Very volatile
Operating Income9.6 B17.1 B10.1 B
Slightly volatile
EBIT11 B17.6 B11.9 B
Slightly volatile
Research Development7.9 B10.7 B8.8 B
Slightly volatile
EBITDA15.2 B23 B17.2 B
Slightly volatile
Cost Of Revenue13 B13.7 B14.4 B
Slightly volatile
Total Operating Expenses22.4 B24 B23.4 B
Pretty Stable
Income Before Tax10.5 B16.4 B11.2 B
Slightly volatile
Net Income10.1 B14.1 B11.1 B
Slightly volatile
Income Tax Expense1.5 B2.4 B1.5 B
Pretty Stable
Net Income Applicable To Common Shares10.4 B14 B11.2 B
Slightly volatile
Net Income From Continuing Ops11.4 B14 B10.2 B
Slightly volatile
Tax Provision1.8 B2.4 B1.5 B
Slightly volatile
Interest Income1.9 B1.2 B1.4 B
Pretty Stable
Reconciled Depreciation7.2 B5.3 B6.4 B
Slightly volatile

Novartis Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow9.7 B17.7 B10.7 B
Slightly volatile
Begin Period Cash Flow7.8 B11.5 B8.7 B
Slightly volatile
Depreciation4.4 B5.4 B5.6 B
Slightly volatile
Capital Expenditures2.6 B1.6 B2.8 B
Very volatile
Total Cash From Operating Activities12.3 B19.2 B13.5 B
Slightly volatile
Net Income9.2 B14.1 B9.8 B
Slightly volatile
End Period Cash Flow8 B11.4 B9 B
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.914.69243.8141
Slightly volatile
Dividend Yield0.02410.03060.0348
Very volatile
PTB Ratio6.115.81483.3983
Slightly volatile
Days Sales Outstanding62.0569.815376.8821
Slightly volatile
Book Value Per Share17.8523.991626.2516
Pretty Stable
Free Cash Flow Yield0.04820.06880.0587
Very volatile
Operating Cash Flow Per Share10.8610.34316.348
Slightly volatile
Stock Based Compensation To Revenue0.01220.01820.0155
Slightly volatile
Capex To Depreciation0.280.29070.5305
Slightly volatile
PB Ratio6.115.81483.3983
Slightly volatile
EV To Sales3.15.14024.1451
Slightly volatile
Free Cash Flow Per Share9.989.50685.1199
Slightly volatile
ROIC0.110.16170.0932
Slightly volatile
Inventory Turnover1.712.27752.2409
Slightly volatile
Net Income Per Share7.937.55535.1275
Slightly volatile
Days Of Inventory On Hand195160169
Pretty Stable
Payables Turnover3.773.20413.1252
Slightly volatile
Sales General And Administrative To Revenue0.05730.0510.0481
Slightly volatile
Research And Ddevelopement To Revenue0.140.1960.1814
Slightly volatile
Capex To Revenue0.04580.02840.0587
Pretty Stable
Cash Per Share4.15.97355.27
Slightly volatile
POCF Ratio15.2713.366314.1046
Pretty Stable
Interest Coverage19.1614.383613.5327
Slightly volatile
Payout Ratio0.410.55910.6186
Very volatile
Capex To Operating Cash Flow0.07680.08090.2087
Slightly volatile
PFCF Ratio19.6214.542218.1816
Pretty Stable
Days Payables Outstanding90.99114124
Slightly volatile
Income Quality1.111.3691.4624
Very volatile
ROE0.330.31780.1987
Slightly volatile
EV To Operating Cash Flow16.1414.641915.2727
Very volatile
PE Ratio19.1518.298418.3484
Very volatile
Return On Tangible Assets0.130.24190.1795
Slightly volatile
EV To Free Cash Flow20.7215.9319.6701
Pretty Stable
Earnings Yield0.05060.05460.0604
Very volatile
Intangibles To Total Assets0.280.47570.4508
Pretty Stable
Net Debt To EBITDA1.121.06780.9667
Slightly volatile
Current Ratio1.651.11671.2321
Pretty Stable
Receivables Turnover5.255.22814.767
Pretty Stable
Graham Number35.2263.574452.2542
Slightly volatile
Shareholders Equity Per Share17.7323.775626.1966
Pretty Stable
Debt To Equity0.840.80280.461
Slightly volatile
Capex Per Share0.820.83641.2246
Very volatile
Revenue Per Share30.9429.462521.7487
Slightly volatile
Interest Debt Per Share20.7119.725112.3111
Slightly volatile
Debt To Assets0.340.32040.2248
Slightly volatile
Enterprise Value Over EBITDA13.1512.256412.1761
Very volatile
Short Term Coverage Ratios3.813.63252.2338
Slightly volatile
Price Earnings Ratio19.1518.298418.3484
Very volatile
Operating Cycle280230247
Pretty Stable
Price Book Value Ratio6.115.81483.3983
Slightly volatile
Days Of Payables Outstanding90.99114124
Slightly volatile
Dividend Payout Ratio0.410.55910.6186
Very volatile
Price To Operating Cash Flows Ratio15.2713.366314.1046
Pretty Stable
Price To Free Cash Flows Ratio19.6214.542218.1816
Pretty Stable
Pretax Profit Margin0.190.29990.2333
Pretty Stable
Ebt Per Ebit0.880.96261.1047
Very volatile
Operating Profit Margin0.170.31150.2081
Slightly volatile
Effective Tax Rate0.170.14590.1441
Slightly volatile
Company Equity Multiplier1.462.50531.9224
Slightly volatile
Long Term Debt To Capitalization0.410.39080.2382
Slightly volatile
Total Debt To Capitalization0.470.44530.3056
Slightly volatile
Return On Capital Employed0.140.20170.1176
Slightly volatile
Debt Equity Ratio0.840.80280.461
Slightly volatile
Ebit Per Revenue0.170.31150.2081
Slightly volatile
Quick Ratio1.330.88680.9716
Very volatile
Dividend Paid And Capex Coverage Ratio1.872.0441.5085
Pretty Stable
Net Income Per E B T0.780.85521.0067
Very volatile
Cash Ratio0.430.41920.3556
Slightly volatile
Cash Conversion Cycle155116121
Pretty Stable
Operating Cash Flow Sales Ratio0.220.35110.2778
Slightly volatile
Days Of Inventory Outstanding195160169
Pretty Stable
Days Of Sales Outstanding62.0569.815376.8821
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.620.91910.7734
Pretty Stable
Cash Flow Coverage Ratios0.860.54190.5741
Pretty Stable
Price To Book Ratio6.115.81483.3983
Slightly volatile
Fixed Asset Turnover2.714.62793.4236
Slightly volatile
Capital Expenditure Coverage Ratio12.9912.36695.5408
Slightly volatile
Price Cash Flow Ratio15.2713.366314.1046
Pretty Stable
Enterprise Value Multiple13.1512.256412.1761
Very volatile
Debt Ratio0.340.32040.2248
Slightly volatile
Cash Flow To Debt Ratio0.860.54190.5741
Pretty Stable
Price Sales Ratio2.914.69243.8141
Slightly volatile
Return On Assets0.080.12680.0952
Slightly volatile
Asset Turnover0.510.49460.4248
Very volatile
Net Profit Margin0.180.25640.2304
Slightly volatile
Gross Profit Margin0.790.75020.7049
Slightly volatile
Price Fair Value6.115.81483.3983
Slightly volatile
Return On Equity0.330.31780.1987
Slightly volatile

Novartis Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap111.2 B177.4 B173.7 B
Slightly volatile
Enterprise Value117.3 B195.2 B188.7 B
Slightly volatile

Novartis Fundamental Market Drivers

Forward Price Earnings17.6056
Cash And Short Term Investments11.6 B

Novartis Upcoming Events

31st of January 2024
Upcoming Quarterly Report
View
23rd of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
31st of January 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Novartis Financial Statements

Novartis shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Novartis investors may analyze each financial statement separately, they are all interrelated. The changes in Novartis' assets and liabilities, for example, are also reflected in the revenues and expenses on on Novartis' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue146.1 M136 M
Total Revenue54.8 B45.1 B
Cost Of Revenue13.7 B13 B
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 0.05  0.06 
Research And Ddevelopement To Revenue 0.20  0.14 
Capex To Revenue 0.03  0.05 
Revenue Per Share 29.46  30.94 
Ebit Per Revenue 0.31  0.17 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Novartis Stock Analysis

When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY